Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
THE YEAR OF THE PANDEMIC:Insights from the Frontlines
November 10, 2020
Introduction
Todd W. Polyniak, CPA
Partner
Stephen J. Ehrenberg, CPA, MBT
Partner
Josh Chananie, CPA
Partner
KEVIN J. SLAVIN
President & CEO
JOSEPH M. DUFFY,
MD FAAFP
Chief Medical Officer
SUSAN E. REED,
CPA, CFP®
Partner-in-Charge
Healthcare Practice
DEBORAH NAPPI,
CPA, MST
Director
Healthcare Practice
The Year of the Pandemic:
Insights from the Frontlines
Kevin J. SlavinPresident & CEO
Dr. Joseph DuffyChief Medical Officer
153 Years of Service to New Jersey
Among Largest & Premier Healthcare Systems
State Safety Net Hospital – Charity Care
Major Academic & Teaching Center
Largest Employer in Passaic County
Care During Pandemics
Historical NJ Pandemics:• 1899 Diphtheria
• 1905 Typhoid
• 1906 Smallpox
• 1918 Influenza
St. Joseph’s Hospital - Circa 1905
Impact of Coronavirus in
New Jersey
o Governor’s COVID-19 Task Force o NJDOH Advisory Committeeo NJHA Chairman o Northern NJ Hospital Response
State-Wide Coordination
• Morgue Overcapacity
• Distribution of Drugs
• Ventilators / PPE
• More Hospital Beds
St. Joseph’s Health
• 456 COVID-19 inpatients
• 107 on ventilators
New Jersey
• 8,000 COVID-19 patients
• 5,025 in Northern NJ
New Jersey at The PeakApril 15, 2020
COVID-19 Admissions Spike in April
0
10
20
30
40
50
60
April 15, 2020: COVID-19 Peaks at St. Joseph’s with 456 Hospitalized Patients
November 10, 2020: Today at St. Joseph’s 93 COVID-19 Hospitalized Patients
* Close monitoring continues as St. Joseph’s prepares for another surge
April May June July Aug Sept Oct
456
Where We Are Today
• 2,621 total cases
• 93 COVID-19 hospitalized patients
• 256,653 total cases
• 1,537 COVID-19 hospitalized patients
St. Joseph’s HealthNew Jersey
“Second Wave is Upon Us."Governor Murphy – November 2020
Leading in Time of Crisis
Collaborationstate/regional/local levels
Innovation at all levels / from all corners
Resiliencepeople are the difference
Understanding the
CoronavirusWhat We’ve Learned
& What Lies Ahead
Dr. Joseph DuffyChief Medical Officer
A wide range of symptoms –from mild symptoms to severe
Mainly respiratory illness and related side-affects
Most recover without requiring special treatment.
Older people, and those with underlying medical problems, are more likely to develop a serious case
What We Know
The U.S. Food and Drug Administration approved the antiviral drug Remdesivir for use in adult and pediatric patients 12 years of age and older.
Treatment for
COVID-19
Multiple COVID-19 vaccines are under development
Four vaccines are in phase 3 clinical trials in the United States
Once approved - there may be a limited supply
“I got admitted to my own hospital. I’m one of the luckiest men on Earth to be in a hospital where people are geared to do this… to keep people alive.”
-- James Pruden, MD, on “60 Minutes”
Questions & Answers
Todd W. Polyniak, CPA
Partner
Stephen J. Ehrenberg, CPA, MBT
Partner
Josh Chananie, CPA
Partner
KEVIN J. SLAVIN
President & CEO
JOSEPH M. DUFFY,
MD FAAFP
Chief Medical Officer
SUSAN E. REED,
CPA, CFP®
Partner-in-Charge
Healthcare Practice
DEBORAH NAPPI,
CPA, MST
Director
Healthcare Practice
• For additional questions: Email [email protected]
• Visit Sax’s COVID-19 Resource Center found on
Saxllp.com to register and for on-going information and
resources.
GiveToStJosephs.org
Thank You!